BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9548501)

  • 1. C1q augments platelet activation in response to aggregated Ig.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1997 Dec; 159(11):5594-8. PubMed ID: 9548501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG.
    Vollertsen RS; McDuffie FC; Bowie EJ
    Clin Exp Immunol; 1983 May; 52(2):423-9. PubMed ID: 6602680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody to the type II Fc receptor for human IgG blocks potentiation of monocyte and neutrophil IgG-induced respiratory burst activation by aggregated C-reactive protein.
    Zeller JM; Sullivan BL
    Cell Immunol; 1993 Jun; 149(1):144-54. PubMed ID: 8513509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement component C1q induces endothelial cell adhesion and spreading through a docking/signaling partnership of C1q receptors and integrins.
    Ghebrehiwet B; Feng X; Kumar R; Peerschke EI
    Int Immunopharmacol; 2003 Mar; 3(3):299-310. PubMed ID: 12639807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel 33-kDa C1q-binding site on human blood platelets.
    Peerschke EI; Reid KB; Ghebrehiwet B
    J Immunol; 1994 Jun; 152(12):5896-901. PubMed ID: 8207215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
    van den Dobbelsteen ME; van der Woude FJ; Schroeijers WE; Klar-Mohamad N; van Es LA; Daha MR
    J Immunol; 1993 Oct; 151(8):4315-24. PubMed ID: 8409404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein I.
    Arvieux J; Roussel B; Pouzol P; Colomb MG
    Thromb Haemost; 1993 Aug; 70(2):336-41. PubMed ID: 8236145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of thromboxane A2 and prostaglandin i2 affected by interaction of heat aggregated IgG, endothelial cells, and platelets in lupus nephritis.
    Kaneko N; Masuyama J; Nara H; Hirata D; Iwamoto M; Okazaki H; Minota S; Yoshio T
    J Rheumatol; 2002 Oct; 29(10):2106-13. PubMed ID: 12375319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc gamma receptor-mediated interplatelet activation by a monoclonal antibody against beta 2 microglobulin.
    Rubinstein E; Boucheix C; Urso I; Carroll RC
    J Immunol; 1991 Nov; 147(9):3040-6. PubMed ID: 1833461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood platelets possess specific binding sites for C1q.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet receptors for the complement component C1q: implications for hemostasis and thrombosis.
    Peerschke EI; Ghebrehiwet B
    Immunobiology; 1998 Aug; 199(2):239-49. PubMed ID: 9777409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet interactions with C1q in whole blood and in the presence of immune complexes or aggregated IgG.
    Peerschke EI; Ghebrehiwet B
    Clin Immunol Immunopathol; 1992 Apr; 63(1):45-50. PubMed ID: 1591882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic aggregation of human blood platelets and its inhibition in vitro].
    Malberg K; Elendt D; Elendt B
    Allerg Immunol (Leipz); 1986; 32(3):153-67. PubMed ID: 2947439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of Platelet Fc-receptor-dependent Response to Activating Monoclonal Antibodies.
    Mazurov AV; Vinogradov DV; Vlasik TN; Burns GF; Berndt MC
    Platelets; 1992; 3(4):181-8. PubMed ID: 21043876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of C1 subcomponents in platelet aggregation induced by aggregated IgG].
    Wautier JL; Souchon H; Peltier AP; Caen JP
    Ann Immunol (Paris); 1977; 128(1-2):81-2. PubMed ID: 848910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.